{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:43:59Z","timestamp":1790876639822,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA044579"],"award-info":[{"award-number":["P30-CA044579"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008231","name":"Arkansas Biosciences Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008457","name":"University of Virginia","doi-asserted-by":"publisher","award":["SCR_017829"],"award-info":[{"award-number":["SCR_017829"]}],"id":[{"id":"10.13039\/100008457","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annemergmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.annemergmed.2025.06.618","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T06:19:54Z","timestamp":1755497994000},"page":"292-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prevalence of Adverse Drug Reactions: Comparing Crotalidae Immune Polyvalent Antivenoms F(ab\u2019)2 and F(ab) in a Galactose-alpha-1,3-galactose (alpha-gal) Endemic Area"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2749-0217","authenticated-orcid":false,"given":"Ari B.","family":"Filip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collette","family":"Tilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howell R.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawn","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Banner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.E.","family":"Platts-Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela Schoppee","family":"Bortz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Charlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annemergmed.2025.06.618_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.toxicon.2022.03.017","article-title":"Fashionably late: a characterization of late coagulopathies in rattlesnake envenomations between Fab and F(ab')2 antivenoms","volume":"212","author":"Dudley","year":"2022","journal-title":"Toxicon"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/15563650.2014.974263","article-title":"Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial","volume":"53","author":"Bush","year":"2015","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.toxicon.2020.08.002","article-title":"Comparison of F(ab')2 and Fab antivenoms in rattlesnake envenomation: first year's post-marketing experience with F(ab')2 in New Mexico","volume":"186","author":"Mascarenas","year":"2020","journal-title":"Toxicon"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib5","doi-asserted-by":"crossref","first-page":"17755","DOI":"10.1016\/S0021-9258(19)77900-9","article-title":"Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells","volume":"263","author":"Galili","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib6","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jaci.2009.08.026","article-title":"Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant","volume":"124","author":"Commins","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaci.2008.10.052","article-title":"Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose","volume":"123","author":"Commins","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib8","doi-asserted-by":"crossref","first-page":"e1545","DOI":"10.1542\/peds.2012-2585","article-title":"Galactose-alpha-1,3-galactose and delayed anaphylaxis, angioedema, and urticaria in children","volume":"131","author":"Kennedy","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ttbdis.2021.101674","article-title":"Tick exposures and alpha-gal syndrome: A systematic review of the evidence","volume":"12","author":"Young","year":"2021","journal-title":"Ticks Tick Borne Dis"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.anai.2022.11.021","article-title":"Tick bite as a risk factor for alpha-gal-specific immunoglobulin E antibodies and development of alpha-gal syndrome","volume":"130","author":"Kersh","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib11","doi-asserted-by":"crossref","first-page":"815","DOI":"10.15585\/mmwr.mm7230a2","article-title":"Geographic distribution of suspected alpha-gal syndrome cases - United States, January 2017-December 2022","volume":"72","author":"Thompson","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib12","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/all.16003","article-title":"Tick bites, IgE to galactose-alpha-1,3-galactose and urticarial or anaphylactic reactions to mammalian meat: the alpha-gal syndrome","volume":"79","author":"Wilson","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jaip.2023.10.046","article-title":"Alpha-Gal IgE prevalence patterns in the United States: an investigation of 3,000 military recruits","volume":"12","author":"Ailsworth","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib14","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMoa074943","article-title":"Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose","volume":"358","author":"Chung","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/1744666X.2020.1782745","article-title":"Diagnosis & management of alpha-gal syndrome: lessons from 2,500 patients","volume":"16","author":"Commins","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40629-016-0099-z","article-title":"Clinical spectrum of alpha-Gal syndrome: from immediate-type to delayed immediate-type reactions to mammalian innards and meat","volume":"25","author":"Fischer","year":"2016","journal-title":"Allergo J Int"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib17","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jaip.2020.10.026","article-title":"alpha-Gal on Crotalidae-polyvalent Fab antivenom (CroFab): investigating the relevance to immediate hypersensitivity reactions","volume":"9","author":"Straesser","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib18","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/all.13073","article-title":"Alpha-gal is a possible target of IgE-mediated reactivity to antivenom","volume":"72","author":"Fischer","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/24734306.2024.2392459","article-title":"Anaphylaxis in Alpha-Gal patients treated with F(ab\u2019)2 for snake bite venom","volume":"8","author":"Wai","year":"2024","journal-title":"Toxicol Commun"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib21","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3390\/diagnostics14131403","article-title":"Basophil activation test predicts cetuximab anaphylaxis severity in alpha-gal IgE-positive patients","volume":"14","author":"Kopa\u010d","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib22","first-page":"63","article-title":"Measurement of the oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal) in pit viper antivenom [ACMT abstract 178]","volume":"19","author":"Griffiths","year":"2023","journal-title":"Journal of Medical Toxicology"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.annemergmed.2014.03.025","article-title":"Looking through the retrospectoscope: reducing bias in emergency medicine chart review studies","volume":"64","author":"Kaji","year":"2014","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib24","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12245-009-0093-z","article-title":"Visual representation of National Institute of Allergy and Infectious Disease and Food Allergy and Anaphylaxis Network criteria for anaphylaxis","volume":"2","author":"Manivannan","year":"2009","journal-title":"Int J Emerg Med"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2018.10.029","article-title":"IgE to galactose-alpha-1,3-galactose and the alpha-Gal syndrome: Insights from basophil activation testing","volume":"143","author":"Wilson","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaci.2018.06.049","article-title":"The basophil activation test differentiates between patients with alpha-gal syndrome and asymptomatic alpha-gal sensitization","volume":"143","author":"Mehlich","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib30","unstructured":"R Core Team (2022). R: A language and environment for Statistical Computing. 4.2.0 ed. Vienna, Austria: R Foundation for Statistical Computing; 2022."},{"key":"10.1016\/j.annemergmed.2025.06.618_bib31","first-page":"S1","article-title":"Allergy diagnostic testing: an updated practice parameter","volume":"100","author":"Bernstein","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib32","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.10.007","article-title":"Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel","volume":"126","author":"Panel","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib33","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/cea.12964","article-title":"Road map for the clinical application of the basophil activation test in food allergy","volume":"47","author":"Santos","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.alit.2019.04.001","article-title":"Alpha-gal-containing biologics and anaphylaxis","volume":"68","author":"Chinuki","year":"2019","journal-title":"Allergol Int"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib35","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1016\/j.jtcvs.2021.03.100","article-title":"Allergic response to medical products in patients with alpha-gal syndrome","volume":"164","author":"Kuravi","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40521-020-00242-2","article-title":"Hypersensitivity reactions to biologicals: from bench to bedside","volume":"7","author":"Akarsu","year":"2020","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib37","doi-asserted-by":"crossref","DOI":"10.1080\/24734306.2024.2314314","article-title":"Hypersensitivity reactions due to North American pit viper antivenom administration and confirmed elevation of alpha-gal IgE","volume":"8","author":"Banner","year":"2024","journal-title":"Toxicology Communications"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/15563650.2018.1504956","article-title":"Incidence of allergic reactions to Crotalidae polyvalent immune Fab","volume":"57","author":"Khobrani","year":"2019","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.annemergmed.2025.06.618_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxcx.2020.100054","article-title":"Serum IgE against galactose-alpha-1,3-galactose is common in Laotian patients with snakebite envenoming but not the major trigger for early anaphylactic reactions to antivenom","volume":"7","author":"Blessmann","year":"2020","journal-title":"Toxicon X"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019606442501039X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019606442501039X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:54:53Z","timestamp":1780908893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019606442501039X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S019606442501039X"],"URL":"https:\/\/doi.org\/10.1016\/j.annemergmed.2025.06.618","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of Adverse Drug Reactions: Comparing Crotalidae Immune Polyvalent Antivenoms F(ab\u2019)2 and F(ab) in a Galactose-alpha-1,3-galactose (alpha-gal) Endemic Area","name":"articletitle","label":"Article Title"},{"value":"Annals of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annemergmed.2025.06.618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Emergency Physicians.","name":"copyright","label":"Copyright"}]}}